[144] Charles River Laboratories International, Inc. SEC Filing
Charles River Laboratories (CRL) Form 144 discloses a proposed sale of 22,500 shares of common stock through Merrill Lynch on or about 08/18/2025 with an aggregate market value of $3,420,000. The notice identifies the seller as Richard Wallman and shows prior acquisitions by the seller including RSU vesting from 2017鈥�2019 and multiple open-market purchases in June鈥揓uly 2025 totaling 15,000 shares. The filing also reports recent sales by the same person in the past three months: 4,000 shares on 06/23/2025 for $550,000 and 8,500 shares on 07/21/2025 for $1,275,000. The filer certifies no undisclosed material adverse information.
Charles River Laboratories (CRL) 鈥� Il modulo Form 144 segnala la proposta di vendita di 22.500 azioni ordinarie tramite Merrill Lynch intorno al 18/08/2025, per un valore di mercato complessivo di $3.420.000. Il comunicato indica il venditore come Richard Wallman e riporta acquisizioni precedenti da parte sua, tra cui vesting di RSU nel periodo 2017鈥�2019 e acquisti sul mercato aperto tra giugno e luglio 2025 per un totale di 15.000 azioni. La pratica riporta inoltre vendite recenti della stessa persona nei tre mesi precedenti: 4.000 azioni il 23/06/2025 per $550.000 e 8.500 azioni il 21/07/2025 per $1.275.000. Il dichiarante certifica l鈥檃ssenza di informazioni materiali sfuggite alla divulgazione.
Charles River Laboratories (CRL) 鈥� El Formulario 144 publica una propuesta de venta de 22.500 acciones ordinarias a trav茅s de Merrill Lynch alrededor del 18/08/2025, con un valor de mercado agregado de $3.420.000. El aviso identifica al vendedor como Richard Wallman y muestra adquisiciones previas por parte de 茅ste, incluyendo la consolidaci贸n de RSU entre 2017 y 2019 y varias compras en el mercado abierto en junio鈥搄ulio de 2025 por un total de 15.000 acciones. La presentaci贸n tambi茅n informa ventas recientes por la misma persona en los 煤ltimos tres meses: 4.000 acciones el 23/06/2025 por $550.000 y 8.500 acciones el 21/07/2025 por $1.275.000. El declarante certifica que no existe informaci贸n material no divulgada.
Charles River Laboratories (CRL) 鈥� Form 144電� 2025雲� 8鞗� 18鞚缄步 Merrill Lynch毳� 韱淀暣 氤错喌欤� 22,500欤茧ゼ 毵る弰頃橂牑電� 瓿勴殟鞚� 瓿奠嫓頄堨溂氅�, 齑� 鞁滉皜鞎§潃 $3,420,000鞛呺媹雼�. 韱奠靹滊姅 韺愲Г鞛愲ゼ Richard Wallman鞙茧 氇呾嫓頃橁碃 鞛堨溂氅�, 2017鈥�2019雲勳潣 RSU 氩犾姢韺呹臣 2025雲� 6鈥�7鞗旍棎 瓯胳箿 瓿店皽鞁滌灔 毵れ垬搿� 頃╆硠 15,000欤茧ゼ 旆摑頃� 旮半鞚� 氤挫棳欷嶋媹雼�. 頃措嫻 鞝滌稖靹滊電� 霕愴暅 霃欖澕鞚胳澊 斓滉芳 3臧滌洈 雮挫棎 鞁滍枆頃� 毵る弰雮挫棴霃� 氤搓碃頃╇媹雼�: 2025/06/23鞐� 4,000欤茧ゼ $550,000鞐�, 2025/07/21鞐� 8,500欤茧ゼ $1,275,000鞐� 毵る弰頄堨姷雼堧嫟. 鞝滌稖鞚胳潃 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 氤挫頃╇媹雼�.
Charles River Laboratories (CRL) 鈥� Le formulaire 144 r茅v猫le une proposition de vente de 22 500 actions ordinaires via Merrill Lynch aux alentours du 18/08/2025, pour une valeur marchande totale de $3 420 000. L鈥檃vis identifie le vendeur comme Richard Wallman et indique des acquisitions ant茅rieures le concernant, notamment le vesting de RSU entre 2017 et 2019 et plusieurs achats sur le march茅 ouvert en juin鈥搄uillet 2025 pour un total de 15 000 actions. Le d茅p么t signale 茅galement des ventes r茅centes par la m锚me personne au cours des trois derniers mois : 4 000 actions le 23/06/2025 pour $550 000 et 8 500 actions le 21/07/2025 pour $1 275 000. Le d茅clarant certifie l鈥檃bsence d鈥檌nformations d茅favorables mat茅rielles non divulgu茅es.
Charles River Laboratories (CRL) 鈥� Das Formular 144 weist den geplanten Verkauf von 22.500 Stammaktien 眉ber Merrill Lynch um den 18.08.2025 aus, mit einem gesamten Marktwert von $3.420.000. Die Mitteilung nennt den Verk盲ufer als Richard Wallman und dokumentiert fr眉here Erwerbe, darunter RSU-Vesting in den Jahren 2017鈥�2019 sowie mehrere K盲ufe am freien Markt im Juni鈥揓uli 2025 in H枚he von insgesamt 15.000 Aktien. Die Einreichung berichtet zudem 眉ber j眉ngste Verk盲ufe derselben Person in den letzten drei Monaten: 4.000 Aktien am 23.06.2025 f眉r $550.000 und 8.500 Aktien am 21.07.2025 f眉r $1.275.000. Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.
- Planned sale fully disclosed with broker, share count (22,500) and aggregate market value ($3,420,000)
- Acquisition history provided, showing RSU vesting and recent open-market purchases which clarify holding origins and compliance with Rule 144
- Prior sales reported for transparency: 4,000 shares (06/23/2025) for $550,000 and 8,500 shares (07/21/2025) for $1,275,000
- Insider selling a significant block of 22,500 shares estimated at $3.42M, which may be perceived negatively by some investors
- Substantial prior dispositions in the past three months totaling 12,500 shares and $1.825M in gross proceeds
Insights
TL;DR: Insider Richard Wallman plans to sell 22,500 CRL shares (~$3.42M) after recent purchases and partial dispositions, a disclosure of routine insider liquidity.
The Form 144 is a routine regulatory notice showing proposed disposition of 22,500 shares via Merrill Lynch with an indicated market value of $3.42 million. The seller's holdings originate from RSU vestings (2017鈥�2019) and recent open-market purchases in June鈥揓uly 2025. The filing also documents prior sales in June and July 2025 totaling 12,500 shares and gross proceeds of $1.825 million. For investors, this is a transparency filing; it does not include operational or financial performance data.
TL;DR: Disclosure complies with Rule 144; indicates insider liquidity activity but contains no governance changes or undisclosed material events.
The notice satisfies Rule 144 requirements by specifying the class, broker, number of shares, acquisition history, and recent sales. Acquisition details show a mix of RSU vesting and recent market purchases, which is relevant for assessing holding period and resale eligibility. The signer affirms absence of undisclosed material adverse information. There are no indications of orchestrated insider transfers, change in control, or governance actions in this filing.
Charles River Laboratories (CRL) 鈥� Il modulo Form 144 segnala la proposta di vendita di 22.500 azioni ordinarie tramite Merrill Lynch intorno al 18/08/2025, per un valore di mercato complessivo di $3.420.000. Il comunicato indica il venditore come Richard Wallman e riporta acquisizioni precedenti da parte sua, tra cui vesting di RSU nel periodo 2017鈥�2019 e acquisti sul mercato aperto tra giugno e luglio 2025 per un totale di 15.000 azioni. La pratica riporta inoltre vendite recenti della stessa persona nei tre mesi precedenti: 4.000 azioni il 23/06/2025 per $550.000 e 8.500 azioni il 21/07/2025 per $1.275.000. Il dichiarante certifica l鈥檃ssenza di informazioni materiali sfuggite alla divulgazione.
Charles River Laboratories (CRL) 鈥� El Formulario 144 publica una propuesta de venta de 22.500 acciones ordinarias a trav茅s de Merrill Lynch alrededor del 18/08/2025, con un valor de mercado agregado de $3.420.000. El aviso identifica al vendedor como Richard Wallman y muestra adquisiciones previas por parte de 茅ste, incluyendo la consolidaci贸n de RSU entre 2017 y 2019 y varias compras en el mercado abierto en junio鈥搄ulio de 2025 por un total de 15.000 acciones. La presentaci贸n tambi茅n informa ventas recientes por la misma persona en los 煤ltimos tres meses: 4.000 acciones el 23/06/2025 por $550.000 y 8.500 acciones el 21/07/2025 por $1.275.000. El declarante certifica que no existe informaci贸n material no divulgada.
Charles River Laboratories (CRL) 鈥� Form 144電� 2025雲� 8鞗� 18鞚缄步 Merrill Lynch毳� 韱淀暣 氤错喌欤� 22,500欤茧ゼ 毵る弰頃橂牑電� 瓿勴殟鞚� 瓿奠嫓頄堨溂氅�, 齑� 鞁滉皜鞎§潃 $3,420,000鞛呺媹雼�. 韱奠靹滊姅 韺愲Г鞛愲ゼ Richard Wallman鞙茧 氇呾嫓頃橁碃 鞛堨溂氅�, 2017鈥�2019雲勳潣 RSU 氩犾姢韺呹臣 2025雲� 6鈥�7鞗旍棎 瓯胳箿 瓿店皽鞁滌灔 毵れ垬搿� 頃╆硠 15,000欤茧ゼ 旆摑頃� 旮半鞚� 氤挫棳欷嶋媹雼�. 頃措嫻 鞝滌稖靹滊電� 霕愴暅 霃欖澕鞚胳澊 斓滉芳 3臧滌洈 雮挫棎 鞁滍枆頃� 毵る弰雮挫棴霃� 氤搓碃頃╇媹雼�: 2025/06/23鞐� 4,000欤茧ゼ $550,000鞐�, 2025/07/21鞐� 8,500欤茧ゼ $1,275,000鞐� 毵る弰頄堨姷雼堧嫟. 鞝滌稖鞚胳潃 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 氤挫頃╇媹雼�.
Charles River Laboratories (CRL) 鈥� Le formulaire 144 r茅v猫le une proposition de vente de 22 500 actions ordinaires via Merrill Lynch aux alentours du 18/08/2025, pour une valeur marchande totale de $3 420 000. L鈥檃vis identifie le vendeur comme Richard Wallman et indique des acquisitions ant茅rieures le concernant, notamment le vesting de RSU entre 2017 et 2019 et plusieurs achats sur le march茅 ouvert en juin鈥搄uillet 2025 pour un total de 15 000 actions. Le d茅p么t signale 茅galement des ventes r茅centes par la m锚me personne au cours des trois derniers mois : 4 000 actions le 23/06/2025 pour $550 000 et 8 500 actions le 21/07/2025 pour $1 275 000. Le d茅clarant certifie l鈥檃bsence d鈥檌nformations d茅favorables mat茅rielles non divulgu茅es.
Charles River Laboratories (CRL) 鈥� Das Formular 144 weist den geplanten Verkauf von 22.500 Stammaktien 眉ber Merrill Lynch um den 18.08.2025 aus, mit einem gesamten Marktwert von $3.420.000. Die Mitteilung nennt den Verk盲ufer als Richard Wallman und dokumentiert fr眉here Erwerbe, darunter RSU-Vesting in den Jahren 2017鈥�2019 sowie mehrere K盲ufe am freien Markt im Juni鈥揓uli 2025 in H枚he von insgesamt 15.000 Aktien. Die Einreichung berichtet zudem 眉ber j眉ngste Verk盲ufe derselben Person in den letzten drei Monaten: 4.000 Aktien am 23.06.2025 f眉r $550.000 und 8.500 Aktien am 21.07.2025 f眉r $1.275.000. Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.
FAQ
What does the Form 144 filed for CRL disclose?
Who is the seller named on the CRL Form 144?
Has the seller made other sales recently?
What is the origin of the shares to be sold?
Does the filing state any undisclosed material information?
